cabozantinib tablets i.p 60 mg
A tyrosine kinase inhibitor (TKI) that targets multiple receptors, including MET, VEGFR, and AXL. By inhibiting these, it slows tumour growth, decreases the blood supply to the tumour, and inhibits the spread of cancer cells.
Click to expand
Anti Cancer Tablets
cabozantinib tablets i.p 60 mg
By Natco Pharma Ltd.
Our Price
₹13,000WHO-GMP
ISO Certified
Trusted Exporter
Secure Supply
Strength
60 mg
Packaging
Commonly available in bottles of 30 tablets (a one-month supply).
Type
High-density polyethylene (HDPE) Bottles with a child-resistant cap, packed in a cardboard box.
Shelf Life
24 to 36 months.
A tyrosine kinase inhibitor (TKI) that targets multiple receptors, including MET, VEGFR, and AXL. By inhibiting these, it slows tumour growth, decreases the blood supply to the tumour, and inhibits the spread of cancer cells.
Manufacturer Info
NameNatco Pharma Ltd.
PrescriptionPrescription
Global Compliance
Our products strictly adhere to International Safety Protocols. 2M Pharmaceuticals ensures 100% genuine supply chain monitoring for all export orders.
CABOZANTINIB TABLETS I.P 60 mg
₹13,000